Fundraising Fox

Biotech Series A Investors & VC Firms

1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.

Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
19 people
Dementia Discovery Fund
LondonSeed–Series A
80 people
HLM Venture Partners
BostonSeed–Late Stage$3M – $5M
32 people
Lerer Hippeau
New YorkSeed–Series B$1M – $5M
24 people
HOF Capital
New YorkPre-Seed–Growth$25K – $15M
41 people
Wing
Palo AltoPre-Seed–Series A$200K – $20M
24 people
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
10 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
41 people
Nippon Venture Capital
TokyoPre-Seed–Late Stage$1.5M – $269M
Playground Global
Palo AltoPre-Seed–Series A$1M – $20M
46 people
Longwood Fund
BostonSeed–Series B
50 people
Hatteras Venture Partners
Research TriangleSeed–Series C$500K – $4M
28 people
Connecticut Innovations
New HavenPre-Seed–Growth$500K – $2M
8 people
SMBC Venture Capital
TokyoPre-Seed–Late Stage$2.3M – $269M
27 people
Hyderabad Angels
HyderabadPre-Seed–Series A$60K – $480K
17 people
NV NOM
GroningenSeed–Growth
27 people
Venrock
Palo AltoSeed–Late Stage$500K – $10M
54 people
Colopl Next
TokyoSeed–Growth
16 people
Source Code Capital
BeijingSeed–Growth$2M – $200M
1 person
Premji Invest
Menlo ParkSeed–Late Stage
37 people
Industrifonden
StockholmPre-Seed–Series A$1.1M – $4.3M
35 people
Beyond Next Ventures
TokyoSeed–Series A
38 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
50 people
Deepbridge Capital
ChesterSeed–Growth
33 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.